Zinc Supplementation in Shigella Patients
Effect of Zinc Supplementation on the Immune and Inflammatory Responses of Children to Shigella Flexneri Infection, and Correlation With Clinical Severity of Illness and Growth Following recoveryEffect of Zinc Supplementation on the Immune and Inflammatory Responses of Children to Shigella Flexneri Infection, and Correlation With Clinical Severity of Illness and Growth Following Recovery
1 other identifier
interventional
56
0 countries
N/A
Brief Summary
Shigellosis is a major cause of morbidity and mortality in young children in Bangladesh and other developing countries. Further, the increasing emergence of resistance to a wide range of antibiotics is of great concern. Another major public health problem in Bangladesh is malnutrition, which is closely linked with shigellosis and with a high mortality. In Shigellosis, a heavy nutritional burden is placed on children and vital micronutrients such as vitamin A is lost in the urine. We recently found that the immune response in S. Flexneri infection was lower in children who were severely malnourished (weight-for-age≤65% as a percentage of the National Centre for Health Statistics median) when compared to children with weight-for-age from \>65-75%. T cell responses were primarily affected with lowered CD4/CD8 ratios, lowered proliferative responses to T cell mitogens, Conconavalin A (ConA) and phytohaemagglutinin (PHA). However, proliferation of pheripheral blood mononuclear cells (PBMs) was lowered only in the presence of autologous plasma suggesting that a factor(s) in plasma, probably nutritional, rather than a defect in cells themselves was responsible. In children with S. dysenteriae 1 infection, proliferative responses to PHA were similarly lowered in the presence of autologous plasma but inhibition correlated to lowered transferring levels in plasma and not to the weight-for-age of the children. Also severely malnourished children with either S. flexneri or S. dysenteriae 1 infection were more severely ill. These findingings show that immunity in malnourishrd children with shigella infection is impaired which may lead to more severe illness. As zinc has profound effects on immunity as well as clinical outcome in diarrhoeal diseases, it is possible that zinc deficiency may be a factor in reducing immunity and increasing severity of acute illness in malnourished children with shigellosis. In this study, we will investigate the effect of zinc supplementation, in a double blind placebo controlled trial, on inflammatory responses, outcome of acute illness and growth following recovery from acute illness with S. flexneri infection.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Jan 1999
Typical duration for phase_3
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 1999
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2002
CompletedFirst Submitted
Initial submission to the registry
May 2, 2006
CompletedFirst Posted
Study publicly available on registry
May 3, 2006
CompletedMay 3, 2006
May 1, 2006
May 2, 2006
May 2, 2006
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
Age
Sex
Weight
Body Mass index
Duration of diarrhoea before admission
Stool volume
Dehydration status
Secondary Outcomes (8)
In blood: total and differential WBC counts,C-reactive protein, albumin, serum electrolytes and creatinine concentration
Quantitation of luminal neutriphils
Immune response
Duration of recovery
Presence of blood and mucous in stool
- +3 more secondary outcomes
Interventions
Eligibility Criteria
You may qualify if:
- Age between 12-59 months
- Moderate malnutrition (61-75% Weight / Age - NCHS Median)
- Duration of diarrhoea of 5 days
- Culture confirmed shigella spp in stool on enrolment
You may not qualify if:
- Measles infection in the past six months
- Presence of obvious systemic illnesses
- Severe malnutrition
- Residence in a location requiring a journey of\>2 hour from the Dhaka Hospital of the ICDDR,B
- Refusal to give consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Roy SK, Raqib R, Khatun W, Azim T, Chowdhury R, Fuchs GJ, Sack DA. Zinc supplementation in the management of shigellosis in malnourished children in Bangladesh. Eur J Clin Nutr. 2008 Jul;62(7):849-55. doi: 10.1038/sj.ejcn.1602795. Epub 2007 Jun 6.
PMID: 17554249DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Swapan Kumar Roy, MBBS, M.Sc, Ph. D
International Centre for Diarrhoeal Disease Research, Bangladesh
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
May 2, 2006
First Posted
May 3, 2006
Study Start
January 1, 1999
Study Completion
April 1, 2002
Last Updated
May 3, 2006
Record last verified: 2006-05